SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-047842
Filing Date
2020-08-20
Accepted
2020-08-20 20:17:21
Documents
1
Period of Report
2020-08-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7469
  Complete submission text file 0001209191-20-047842.txt   8849
Mailing Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Issuer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PRINCIPIA BIOPHARMA INC. 220 E. GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Thomas Dolca (Reporting) CIK: 0001768239 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38653 | Film No.: 201121276